-
公开(公告)号:US08592444B2
公开(公告)日:2013-11-26
申请号:US12988197
申请日:2009-04-14
申请人: Mario Varasi , Florian Thaler , Agnese Abate , Giacomo Carenzi , Ciro Mercurio , Saverio Minucci
发明人: Mario Varasi , Florian Thaler , Agnese Abate , Giacomo Carenzi , Ciro Mercurio , Saverio Minucci
IPC分类号: C07D401/04 , A61K31/438
CPC分类号: C07D498/10 , A61K31/438 , C07D471/10 , C07D491/107 , Y02A50/409 , Y02A50/411
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: the dotted line is an optional additional bond; n is zero or an integer from 1 to 4; R1 is hydrogen; C1-C6 alkyl, optionally substituted by cycloalkyl, aryl or by heteroaryl; (CO)R3; (SO2)R4; cycloalkyl; aryl; or heteroaryl; R2 is C1-C6 alkyl, optionally substituted by aryl or by heteroaryl; aryl; heteroaryl; or (CO)R5; X is CH2, oxygen or NR6; Y is a bond, CHR7 or NR8; Z is oxygen, CR9R10 or C═R11; and R3, R4, R5, R6, R7, R8, R9, R10 and R11 are as further defined in the specification; and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:虚线是任选的附加键; n为0或1至4的整数; R1是氢; 任选被环烷基,芳基或杂芳基取代的C 1 -C 6烷基; (CO)R3; (SO2)R4; 环烷基 芳基; 或杂芳基; R2是任选被芳基或杂芳基取代的C 1 -C 6烷基; 芳基; 杂芳基; 或(CO)R5; X是CH 2,氧或NR 6; Y是一个键,CHR7或NR8; Z是氧,CR9R10或C = R11; R3,R4,R5,R6,R7,R8,R9,R10和R11在说明书中进一步定义; 及其药学上可接受的盐。
-
公开(公告)号:US20110039840A1
公开(公告)日:2011-02-17
申请号:US12988197
申请日:2009-04-14
申请人: Mario Varasi , Florian Thaler , Agnese Abate , Giacomo Carenzi , Ciro Mercurio , Saverio Minucci
发明人: Mario Varasi , Florian Thaler , Agnese Abate , Giacomo Carenzi , Ciro Mercurio , Saverio Minucci
IPC分类号: A61K31/537 , C07D491/10 , A61K31/438 , A61P35/00 , A61P31/18 , A61P25/08 , A61P9/10 , A61P37/00 , A61P17/06 , A61P35/04 , A61P25/16 , A61P25/28 , A61P25/18 , A61P33/06 , A61P33/02 , A61P31/10 , A61P31/12 , C07D498/10 , C07D471/10 , A61K31/527 , A61K31/506
CPC分类号: C07D498/10 , A61K31/438 , C07D471/10 , C07D491/107 , Y02A50/409 , Y02A50/411
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: the dotted line is an optional additional bond; n is zero or an integer from 1 to 4; R1 is hydrogen; C1-C6 alkyl, optionally substituted by cycloalkyl, aryl or by heteroaryl; (CO)R3; (SO2)R4; cycloalkyl; aryl; or heteroaryl; R2 is C1-C6 alkyl, optionally substituted by aryl or by heteroaryl; aryl; heteroaryl; or (CO)R5; X is CH2, oxygen or NR6; Y is a bond, CHR7 or NR8; Z is oxygen, CR9R10 or C═R11; and R3, R4, R5, R6, R7, R8, R9, R10 and R11 are as further defined in the specification; and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:虚线是任选的附加键; n为0或1至4的整数; R1是氢; 任选被环烷基,芳基或杂芳基取代的C 1 -C 6烷基; (CO)R3; (SO2)R4; 环烷基 芳基; 或杂芳基; R2是任选被芳基或杂芳基取代的C 1 -C 6烷基; 芳基; 杂芳基; 或(CO)R5; X是CH 2,氧或NR 6; Y是一个键,CHR7或NR8; Z是氧,CR9R10或C = R11; R3,R4,R5,R6,R7,R8,R9,R10和R11在说明书中进一步定义; 及其药学上可接受的盐。
-
公开(公告)号:US20120115867A1
公开(公告)日:2012-05-10
申请号:US13100670
申请日:2011-05-04
申请人: Saverio Minucci , Pier Giuseppe Pelicci , Antonello Mai , Marco Ballarini , Gaetano Gargiulo , Silvio Massa , Florian Thaler , Gilles Pain , Andrea Colombo , Stefania Gagliardi , Mario Varasi , Ciro Mercurio
发明人: Saverio Minucci , Pier Giuseppe Pelicci , Antonello Mai , Marco Ballarini , Gaetano Gargiulo , Silvio Massa , Florian Thaler , Gilles Pain , Andrea Colombo , Stefania Gagliardi , Mario Varasi , Ciro Mercurio
IPC分类号: A61K31/495 , C07D401/10 , A61P35/00 , C07D413/06 , A61K31/5377 , C07D295/155 , A61K31/496
CPC分类号: C07D295/155 , C07D213/54 , C07D401/10
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen or C1-C6 alkyl, R3, R4 are, independently, hydrogen, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl or C1-C6 haloalkoxy, and R5 and R6 are as further defined in the specification, and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:Q是键,CH2,NR5或氧,X是CH或氮,Y是键,CH2,氧或NR6,Z是CH 或氮,R 1,R 2独立地为氢或C 1 -C 6烷基,R 3,R 4独立地为氢,卤素,C 1 -C 6烷基,C 1 -C 6烷氧基,C 1 -C 6卤代烷基或C 1 -C 6卤代烷氧基, 和R6在说明书中进一步定义,及其药学上可接受的盐。
-
公开(公告)号:US20110105474A1
公开(公告)日:2011-05-05
申请号:US12997191
申请日:2009-06-08
申请人: Florian Thaler , Mario Varasi , Stefania Gagliardi , Andrea Colombo , Saverio Minucci , Ciro Mercurio
发明人: Florian Thaler , Mario Varasi , Stefania Gagliardi , Andrea Colombo , Saverio Minucci , Ciro Mercurio
IPC分类号: A61K31/495 , A61K31/55 , A61K31/506 , A61K31/496 , A61K31/444 , A61K31/4545 , A61K31/4439 , A61K31/407 , C07D401/14 , C07D401/06 , C07D295/192 , C07D471/10 , C07D471/04 , C07D401/04 , C07D487/08 , C07D241/04 , A61P35/00
CPC分类号: C07D295/10 , C07D211/58 , C07D295/18 , C07D401/06 , C07D401/14 , C07D471/08 , C07D471/10
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: the dotted line is an optional additional bond; R1 is hydrogen, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl or C1 C6 haloalkoxy; R2, R3 are, independently, hydrogen; C1-C6 alkyl; aryl; or taken together with the carbon atoms to which they are bound form a bridged bicyclic ring or a fused heterocycle; X is CH or nitrogen; Y is a bond, oxygen, (CH2)mCR4R5(CH2)n, or (CH2)oNR6(CH2)p; m, n, o, p, R4, R5 and R6 are as further defined in the specification; and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:虚线是任选的附加键; R 1是氢,卤素,C 1 -C 6烷基,C 1 -C 6烷氧基,C 1 -C 6卤代烷基或C 1 -C 6卤代烷氧基; R2,R3独立地是氢; C1-C6烷基; 芳基; 或与其结合的碳原子一起形成桥连双环或稠合杂环; X是CH或氮; Y是键,氧,(CH 2)m CR 4 R 5(CH 2)n或(CH 2)o NR 6(CH 2)p; m,n,o,p,R4,R5和R6如说明书中进一步定义; 及其药学上可接受的盐。
-
公开(公告)号:US08242175B2
公开(公告)日:2012-08-14
申请号:US12962209
申请日:2010-12-07
申请人: Antonello Mai , Saverio Minucci , Florian Thaler , Gilles Pain , Andrea Colombo , Stefania Gagliardi , Pier Giuseppe Pelicci , Marco Ballarini , Gaetano Gargiulo , Silvio Massa
发明人: Antonello Mai , Saverio Minucci , Florian Thaler , Gilles Pain , Andrea Colombo , Stefania Gagliardi , Pier Giuseppe Pelicci , Marco Ballarini , Gaetano Gargiulo , Silvio Massa
IPC分类号: A61K31/19 , A61K31/5377 , A61K31/495 , A61K31/451 , A61K31/445 , A61K31/5375 , A61K31/496 , A61P35/00 , C07D295/155 , C07D211/58 , C07D401/10 , C07D413/10 , C07C259/06
CPC分类号: C07D401/10 , C07D211/58 , C07D213/50 , C07D213/54 , C07D241/04 , C07D265/30 , C07D295/112 , C07D333/56
摘要: New histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, CH—NR3R4, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen, halogen, C1-C6 alkyl or C1-C6 haloalkyl, R11, R12 are, independently, hydrogen or C1-C6 alkyl, and R3, R4, R5 and R6 are as further defined in the specification.
摘要翻译: 根据通式(I)的新的组蛋白脱乙酰酶抑制剂其中:Q是键,CH2,CH-NR3R4,NR5或氧,X是CH或氮,Y是键,CH2,氧或NR6,Z是CH或 氮,R 1,R 2独立地是氢,卤素,C 1 -C 6烷基或C 1 -C 6卤代烷基,R 11,R 12独立地是氢或C 1 -C 6烷基,R 3,R 4,R 5和R 6如 规格。
-
公开(公告)号:US20140080823A1
公开(公告)日:2014-03-20
申请号:US14088061
申请日:2013-11-22
申请人: Mario Varasi , Florian Thaler , Agnese Abate , Giacomo Carenzi , Ciro Mercurio , Saverio Minucci
发明人: Mario Varasi , Florian Thaler , Agnese Abate , Giacomo Carenzi , Ciro Mercurio , Saverio Minucci
IPC分类号: C07D498/10 , C07D471/10 , C07D491/107
CPC分类号: C07D498/10 , A61K31/438 , C07D471/10 , C07D491/107 , Y02A50/409 , Y02A50/411
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: the dotted line is an optional additional bond; n is zero or an integer from 1 to 4; R1 is hydrogen; C1-C6 alkyl, optionally substituted by cycloalkyl, aryl or by heteroaryl; (CO)R3; (SO2)R4; cycloalkyl; aryl; or heteroaryl; R2 is C1-C6 alkyl, optionally substituted by aryl or by heteroaryl; aryl; heteroaryl; or (CO)R5; X is CH2, oxygen or NR6; Y is a bond, CHR7 or NR8; Z is oxygen, CR9R10 or C═R11; and R3, R4, R5, R6, R7, R8, R9, R10 and R11 are as further defined in the specification; and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:虚线是任选的附加键; n为0或1至4的整数; R1是氢; 任选被环烷基,芳基或杂芳基取代的C 1 -C 6烷基; (CO)R3; (SO2)R4; 环烷基 芳基; 或杂芳基; R2是任选被芳基或杂芳基取代的C 1 -C 6烷基; 芳基; 杂芳基; 或(CO)R5; X是CH 2,氧或NR 6; Y是一个键,CHR7或NR8; Z是氧,CR9R10或C = R11; R3,R4,R5,R6,R7,R8,R9,R10和R11在说明书中进一步定义; 及其药学上可接受的盐。
-
公开(公告)号:US07803800B2
公开(公告)日:2010-09-28
申请号:US11664187
申请日:2005-09-30
申请人: Saverio Minucci , Pier Giuseppe Pelicci , Antonello Mai , Marco Ballarini , Gaetano Gargiulo , Silvio Massa
发明人: Saverio Minucci , Pier Giuseppe Pelicci , Antonello Mai , Marco Ballarini , Gaetano Gargiulo , Silvio Massa
IPC分类号: A61K31/165 , A61K31/341 , A61K31/381 , A61K31/44 , A61K31/4436 , A61K31/5375 , A61P35/00 , C07C259/06 , C07D213/46 , C07D295/155 , C07D307/54 , C07D307/80 , C07D333/24 , C07D333/56 , C07D409/06
CPC分类号: C07C259/06 , C07D207/333 , C07D213/46 , C07D213/54 , C07D295/112 , C07D307/46 , C07D307/80 , C07D333/22 , C07D333/56 , C07D409/06
摘要: New inhibitors of histone deacetylases having antitumor activity, and the process of preparation thereof are herein described. These compounds belong to the structural formula (I) where R1 is a linear or branched chain containing at least two conjugated double bonds, A is an optionally substituted phenyl or pyridyl ring, Ar is an aryl or heteroaryl group, and R3 is hydrogen or alkoxyalkyl. The application also describes the use of said compounds in the treatment of diseases associated to the deregulation of histone deacetylases activity, such as tumors, as well as the relevant pharmaceutical compositions for administration to patients requiring said treatment.
摘要翻译: 本文描述了具有抗肿瘤活性的组蛋白脱乙酰酶的新抑制剂及其制备方法。 这些化合物属于结构式(I),其中R 1是含有至少两个共轭双键的直链或支链,A是任选取代的苯基或吡啶基,Ar是芳基或杂芳基,R 3是氢或烷氧基烷基 。 本申请还描述了所述化合物在治疗与组蛋白脱乙酰酶活性失调相关的疾病如肿瘤中的用途,以及用于给予需要所述治疗的患者的相关药物组合物。
-
公开(公告)号:US20100113438A1
公开(公告)日:2010-05-06
申请号:US12295498
申请日:2007-03-30
申请人: Antonello Mai , Saverio Minucci , Florian Thaler , Gilles Pain , Andrea Colombo , Stefania Gagliardi
发明人: Antonello Mai , Saverio Minucci , Florian Thaler , Gilles Pain , Andrea Colombo , Stefania Gagliardi
IPC分类号: A61K31/535 , C07D401/10 , A61K31/497 , A61K31/4545 , C07D265/30
CPC分类号: C07D211/46 , C07D211/34 , C07D211/58 , C07D213/54 , C07D213/56 , C07D295/112 , C07D295/155 , C07D295/185 , C07D295/192 , C07D295/205 , C07D295/215 , C07D295/26 , C07D401/10
摘要: New histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, CH—NR3R4, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen, halogen, C1-C6 alkyl or C1-C6 haloalkyl, R11, R12 are, independently, hydrogen or C1-C6 alkyl, and R3, R4, R5 and R6 are as further defined in the specification.
摘要翻译: 根据通式(I)的新的组蛋白脱乙酰酶抑制剂其中:Q是键,CH2,CH-NR3R4,NR5或氧,X是CH或氮,Y是键,CH2,氧或NR6,Z是CH或 氮,R 1,R 2独立地是氢,卤素,C 1 -C 6烷基或C 1 -C 6卤代烷基,R 11,R 12独立地是氢或C 1 -C 6烷基,R 3,R 4,R 5和R 6如 规格。
-
公开(公告)号:US09115148B2
公开(公告)日:2015-08-25
申请号:US14088061
申请日:2013-11-22
申请人: DAC S.R.L.
发明人: Mario Varasi , Florian Thaler , Agnese Abate , Giacomo Carenzi , Ciro Mercurio , Saverio Minucci
IPC分类号: A61K31/438 , C07D471/10 , C07D498/10 , C07D491/107
CPC分类号: C07D498/10 , A61K31/438 , C07D471/10 , C07D491/107 , Y02A50/409 , Y02A50/411
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: the dotted line is an optional additional bond; n is zero or an integer from 1 to 4; R1 is hydrogen; C1-C6 alkyl, optionally substituted by cycloalkyl, aryl or by heteroaryl; (CO)R3; (SO2)R4; cycloalkyl; aryl; or heteroaryl; R2 is C1-C6 alkyl, optionally substituted by aryl or by heteroaryl; aryl; heteroaryl; or (CO)R5; X is CH2, oxygen or NR6; Y is a bond, CHR7 or NR8; Z is oxygen, CR9R10 or C═R11; and R3, R4, R5, R6, R7, R8, R9, R10 and R11 are as further defined in the specification; and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:虚线是任选的附加键; n为0或1至4的整数; R1是氢; 任选被环烷基,芳基或杂芳基取代的C 1 -C 6烷基; (CO)R3; (SO2)R4; 环烷基 芳基; 或杂芳基; R2是任选被芳基或杂芳基取代的C 1 -C 6烷基; 芳基; 杂芳基; 或(CO)R5; X是CH 2,氧或NR 6; Y是一个键,CHR7或NR8; Z是氧,CR9R10或C = R11; R3,R4,R5,R6,R7,R8,R9,R10和R11在说明书中进一步定义; 及其药学上可接受的盐。
-
公开(公告)号:US08980877B2
公开(公告)日:2015-03-17
申请号:US13446861
申请日:2012-04-13
申请人: Mario Varasi , Florian Thaler , Raffaella Amici , Agnese Abate , Maria Carmela Fulco , Saverio Minucci , Ciro Mercurio
发明人: Mario Varasi , Florian Thaler , Raffaella Amici , Agnese Abate , Maria Carmela Fulco , Saverio Minucci , Ciro Mercurio
IPC分类号: A61K31/407 , A61K31/438 , A61K31/55 , C07D491/107 , A61K31/397 , A61K31/537 , C07D498/10
CPC分类号: A61K31/397 , A61K31/407 , A61K31/438 , A61K31/537 , A61K31/55 , C07D491/107 , C07D498/10
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I), wherein: m and n are independently zero or an integer from 1 to 4; p is zero or an integer from 1 to 3, with the proviso that when p is zero, n and m cannot be both 1; R is hydrogen; C1-C6 alkyl, optionally substituted by C3-C8 cycloalkyl, C6-C10 aryl or hetero(C2-C9)aryl; (CO)R2; (SO2)R3; C3-C8 cycloalkyl; C6-C10 aryl; or hetero(C2-C9)aryl; R1 is halogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy; Y is CH2 or NR4; Z is C═R5; and R2, R3, R4, and R5 are as further defined in the specification; and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:m和n独立地为0或1至4的整数; p为0或1至3的整数,条件是当p为零时,n和m不能同时为1; R是氢; 任选被C 3 -C 8环烷基,C 6 -C 10芳基或杂(C 2 -C 9)芳基取代的C 1 -C 6烷基; (CO)R2; (SO2)R3; C3-C8环烷基; C6-C10芳基; 或杂(C 2 -C 9)芳基; R1是卤素,C1-C6烷基,C1-C6卤代烷基,C1-C6烷氧基,C1-C6卤代烷氧基; Y是CH 2或NR 4; Z为C = R5; R2,R3,R4和R5如说明书中进一步定义; 及其药学上可接受的盐。
-
-
-
-
-
-
-
-
-